Medicine and Dentistry
Patient
100%
Neoplasm
98%
Glioblastoma
82%
Surgery
60%
Cells
53%
Therapeutic Procedure
46%
Chordoma
39%
Magnetic Resonance Imaging
26%
Tumor Cell
25%
Overall Survival
24%
Epidermal Growth Factor Receptor
23%
Follow up
21%
Progression Free Survival
21%
Analysis
21%
Radiation Therapy
19%
Age
19%
Brain
19%
Facial Nerve
19%
Combination Therapy
18%
Temozolomide
18%
Craniopharyngioma
18%
Survival
17%
Methylation
16%
Recurrent Disease
16%
Radiation
16%
Ganglioglioma
16%
Complication
16%
Systematic Review
15%
Vasculotropin
14%
Xenograft
14%
Diagnosis
13%
Malignant Neoplasm
13%
Rapamycin
12%
Mesenchymal Stem Cell
12%
Blood Brain Barrier
11%
Ependymoma
11%
Skull Surgery
11%
Phosphodiesterase V
11%
Inpatient
11%
Neural Stem Cell
11%
Chemotherapy
10%
Adjuvant Radiotherapy
10%
Microvessel
10%
Growth
10%
Brain Tumor
10%
Bevacizumab
10%
Messenger RNA
10%
Motor Evoked Potential
10%
Adult
10%
Protein
10%
Biochemistry, Genetics and Molecular Biology
Methylation
25%
Stem Cell
24%
Angiogenesis
20%
Growth
18%
Nuclear Magnetic Resonance Spectroscopy
17%
Progression Free Survival
16%
Overall Survival
16%
Electric Potential
15%
Vascular Endothelial Growth Factor
14%
Survival
12%
Phenotype
11%
Epidermal Growth Factor Receptor
11%
Proteomics
11%
Vascular Endothelial Growth Factor
11%
Radiation
11%
Promoter Region
10%
Messenger RNA
9%
Signal Transduction
8%
Reduction (Chemistry)
8%
Bevacizumab
7%
Density
7%
Sample
6%
Gene Expression Profiling
6%
Nested Gene
6%
Ribonucleoprotein
5%
Monocyte
5%
Regorafenib
5%
Oncogene C Myc
5%
Photon
5%
MEG3
5%
Lipid
5%
MicroRNA
5%
Long Non-Coding RNA
5%
SMAD
5%
Decompression
5%
Cellular Immunity
5%
PD-L1
5%
Cell Migration
5%
Aptitude
5%
Cell Growth
5%
Mutation
5%
Blood Level
5%
Modulation
5%
Radiosensitivity
5%
Mesenchymal-Epithelial Transition
5%
Antiangiogenic Activity
5%
Neoangiogenesis
5%
Neuroscience
Chordoma
33%
Methylation
22%
Glioma
20%
Temozolomide
15%
Brain
13%
Glioblastoma Multiforme
13%
Ependymoma
11%
Phosphodiesterase V
11%
Promoter Region
11%
Cell Line
10%
Bevacizumab
10%
Trigeminal Neuralgia
9%
Chemotherapy
9%
In Vivo
8%
Meningioma
8%
Protein
8%
Magnetic Resonance Imaging
7%
Blood Brain Barrier
7%
Phosphatase
6%
Phenotype
5%
Hydrocephalus
5%
Pituitary Surgery
5%
Aminolevulinic Acid
5%
Monocyte
5%
Cavernous Sinus
5%
Craniopharyngioma
5%
Ribonucleoprotein
5%
SOX2
5%
Peripheral Nerve Injury
5%
Prolactinoma
5%
Oncogene C Myc
5%
Regorafenib
5%
Ulnar Nerve
5%
Spinal Cord
5%
Multiple Sclerosis
5%
4-Aminosalicylic Acid
5%
Somatosensory Evoked Potential
5%
Motor Evoked Potential
5%
Brain Tumor
5%
